Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
A
Details...
Enter Symbol
ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA)
Sector: Medical
Current Price :
$9.09
52 Week Low
$3.11
52 Week High
$9.10
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
41M
Market Cap:
$0.38B
Avg Volume:
614852
P/E Ratio:
32.430
PEG Ratio:
1.420
Split:
On 11/14/2002 ista split by factor of 0.100
1m
3m
6m
1y
2y
Opinion and Analysis
ISTA Pharma (ISTA) To File NDA For Prolensa In 1H-2012
May 10, 2012 12:48 PM |
ISTA
Merger Arbitrage Mondays – April 9, 2012
Apr 09, 2012 08:29 AM |
ABB
,
ABVT
,
AEA
,
ALTH
,
APOL
,
AV
U.S. Stocks Retreat After Monday's Rally; Hot Stocks: APOL, LEN, PVH, MMR, DG, ISTA, MAPP, MKC
Mar 27, 2012 04:22 PM |
APOL
,
DG
,
ISTA
,
LEN
,
MAPP
,
MKC
More Articles on ISTA..
Press Releases
ISTA Pharmaceuticals Stockholders Vote to Approve Acquisition by Bausch + Lomb
Jun 05, 2012 02:26 PM |
ISTA
ISTA Pharmaceuticals Highlights PROLENSA(TM) Clinical Data at the 2012 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
May 10, 2012 11:15 AM |
ISTA
ISTA Pharmaceuticals Reports First Quarter 2012 Financial Results
May 03, 2012 04:01 PM |
ISTA
More Press Releases on ISTA..
SEC Filings
Form 4 ISTA PHARMACEUTICALS For: Jun 06 Filed by: MCGINLEY KATHLEEN (10K)
Jun 15, 2012 05:13 PM
Form 4 ISTA PHARMACEUTICALS For: Jun 06 Filed by: McNamara Timothy (10K)
Jun 15, 2012 05:13 PM
Form 4 ISTA PHARMACEUTICALS For: Jun 06 Filed by: HUTT PETER BARTON (10K)
Jun 15, 2012 05:12 PM
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
ISTA
Compare to S&P
YTD
28.79 %
26.73 %
4 Weeks
0.44 %
7.60 %
12 Weeks
6.82 %
14.58 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-84.00 %
EPS Growth in Last Year:
121.05 %
Sales Growth in Last Quarter:
-24.57 %
Sales Growth in Last Quarter:
-7.37 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##